Mutations Define Cross-talk between the N-terminal Nucleotide-binding Domain and Transmembrane Helix-2 of the Yeast Multidrug Transporter Pdr5
Authors:
Open Access
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (50) , 35010-35022
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mapping of Interdomain Interfaces Required for the Functional Architecture of Yor1p, a Eukaryotic ATP-binding Cassette (ABC) TransporterJournal of Biological Chemistry, 2008
- Multidrug Transport by the ABC Transporter Sav1866 fromStaphylococcus aureusBiochemistry, 2008
- A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5Proceedings of the National Academy of Sciences, 2008
- Complete Inhibition of the Pdr5p Multidrug Efflux Pump ATPase Activity by Its Transport Substrate Clotrimazole Suggests that GTP as Well as ATP May Be Used as an Energy SourceBiochemistry, 2007
- Evidence for a Sav1866‐like architecture for the human multidrug transporter P‐glycoproteinThe FASEB Journal, 2007
- The yeast Pdr5p multidrug transporter: How does it recognize so many substrates?Biochemical and Biophysical Research Communications, 2007
- Subcellular trafficking of the yeast plasma membrane ABC transporter, Pdr5, is impaired by a mutation in the N‐terminal nucleotide‐binding foldMolecular Microbiology, 2006
- Characterization of Cdr1p, A Major Multidrug Efflux Protein of Candida albicans: Purified Protein Is Amenable to Intrinsic Fluorescence AnalysisBiochemistry, 2006
- The Role of Hydrogen Bond Acceptor Groups in the Interaction of Substrates with Pdr5p, a Major Yeast Drug TransporterBiochemistry, 2005
- Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic EffluxJournal of Biological Chemistry, 2003